Literature DB >> 22119908

[Compliance enhancement in drug therapy : opportunities and limitations].

L Krolop1, U Jaehde.   

Abstract

In the execution of their pharmacotherapy, many patients deviate from the prescribed treatment regimen. Reasons for noncompliance can be diverse and range from forgetfulness of the patient to attributes of the health care system. Besides increased health care costs, poor compliance causes both an endangerment to the patient and poor health outcomes. Therefore, it is crucial that compliance enhancement receives high priority. In the beginning of this process, noncompliance must be detected in daily practice. Moreover, various methods can provide valuable information about medication-taking behavior, time patterns, and reasons for noncompliance. Based on this assessment, appropriate measures to enhance compliance can be taken. In this article, the opportunities and limitations of compliance enhancement are discussed.

Entities:  

Mesh:

Year:  2012        PMID: 22119908     DOI: 10.1007/s00108-011-2951-z

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  28 in total

Review 1.  Breaking of scored tablets: a review.

Authors:  E van Santen; D M Barends; H W Frijlink
Journal:  Eur J Pharm Biopharm       Date:  2002-03       Impact factor: 5.571

2.  Pharmacodynamics of variable patient compliance: implications for pharmaceutical value.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1998-09-07       Impact factor: 15.470

Review 3.  Forgiveness of non-adherence to HIV-1 antiretroviral therapy.

Authors:  Jonathan Shuter
Journal:  J Antimicrob Chemother       Date:  2008-02-06       Impact factor: 5.790

4.  HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%.

Authors:  Jonathan Shuter; Julie A Sarlo; Tina J Kanmaz; Richard A Rode; Barry S Zingman
Journal:  J Acquir Immune Defic Syndr       Date:  2007-05-01       Impact factor: 3.731

Review 5.  [Strategies to improve medication adherence].

Authors:  U Laufs; M Böhm; H K Kroemer; K Schüssel; N Griese; M Schulz
Journal:  Dtsch Med Wochenschr       Date:  2011-08-01       Impact factor: 0.628

6.  Compliance becomes concordance.

Authors:  P D Mullen
Journal:  BMJ       Date:  1997-03-08

Review 7.  Using pharmacokinetic-pharmacodynamic relationships to predict the effect of poor compliance.

Authors:  Jean-Pierre Boissel; Patrice Nony
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 8.  Adherence to therapy with oral antineoplastic agents.

Authors:  Ann H Partridge; Jerry Avorn; Philip S Wang; Eric P Winer
Journal:  J Natl Cancer Inst       Date:  2002-05-01       Impact factor: 13.506

9.  Predicting compliance with a regimen of digoxin therapy in family practice.

Authors:  J R Gilbert; C E Evans; R B Haynes; P Tugwell
Journal:  Can Med Assoc J       Date:  1980-07-19       Impact factor: 8.262

10.  Compliance assessment of ambulatory Alzheimer patients to aid therapeutic decisions by healthcare professionals.

Authors:  Oliver Schwalbe; Christian Scheerans; Ines Freiberg; Andrea Schmidt-Pokrzywniak; Andreas Stang; Charlotte Kloft
Journal:  BMC Health Serv Res       Date:  2010-08-09       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.